Strong link between polycyclic aromatic hydrocarbons and raised rheumatoid arthritis riskMay 18, 2023Rheumatoid Arthritis
Rheumatology NewsInvestigational drug peresolimab shows efficacy in patients with RAMay 17, 2023Rheumatoid Arthritis
Rheumatology NewsRheumatoid arthritis linked to increased Parkinson’s riskMay 11, 2023Rheumatoid Arthritis
Rheumatology NewsNormal CRP during RA flares: An ‘underappreciated, persistent phenotype’May 5, 2023Rheumatoid Arthritis
Rheumatology NewsFDA puts partial hold on investigational alopecia areata drug deuruxolitinibMay 4, 2023Rheumatoid Arthritis
Rheumatology NewsResearchers seek to understand post-COVID autoimmune disease riskMay 1, 2023COVID-19 UpdatesLong COVIDRheumatoid ArthritisLupus & Connective Tissue Diseases
RA causally associated with ischemic heart disease and myocardial infarctionApril 27, 2023Rheumatoid Arthritis
RA raises risk for bronchial asthma and asthma-related comorbiditiesApril 27, 2023Rheumatoid Arthritis
Meta-analysis reveals superior efficacy and safety outcomes with abatacept in RAApril 27, 2023Rheumatoid Arthritis
Factors to guide individualized benefit-risk assessment and decision-making with tofacitinib in RAApril 27, 2023Rheumatoid Arthritis
Tofacitinib associated with reduced risk of developing ILD in patients with RAApril 27, 2023Rheumatoid Arthritis
